Placebo for TQC3721 inhalation powder

DRUG2 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Chronic Obstructive Pulmonary Disease (COPD)Pulmonary Disease, Chronic Obstructive

Phase 1

A Clinical Study of TQC3721 Inhalation Powder in Patients With Chronic Obstructive Pulmonary Disease

CompletedNCT06748079

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chronic Obstructive Pulmonary Disease (COPD)

Start: 2024-12-03End: 2026-08-07Updated: 2026-08-11

Phase 2

A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder

CompletedNCT07252908

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Pulmonary Disease, Chronic Obstructive

Start: 2025-12-22End: 2026-05-07Updated: 2026-06-18